Tag Archives: relapsing or primary progressive multiple sclerosis (RMS or PPMS)

Roche’s OCREVUS Subcutaneous Injection Shows Promise in Phase III Study for Multiple Sclerosis Treatment

Posted on 12, October 2023 by

(IN BRIEF) Roche has announced positive late-breaking data from the Phase III OCARINA II study, which demonstrates the effectiveness of OCREVUS as a twice-yearly, 10-minute subcutaneous injection for patients with relapsing or primary progressive multiple sclerosis (RMS or PPMS). The … Read the full press release →

Posted in Business, Education, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Switzerland, Technology

Tagged , , , , , , ,